| MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer N Yamashita, M Long, A Fushimi, M Yamamoto, T Hata, M Hagiwara, ... Journal for immunotherapy of cancer 9 (1), 2021 | 57 | 2021 |
| MUC1-C activates the BAF (mSWI/SNF) complex in prostate cancer stem cells M Hagiwara, Y Yasumizu, N Yamashita, H Rajabi, A Fushimi, MD Long, ... Cancer research 81 (4), 1111-1122, 2021 | 55 | 2021 |
| MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells M Hagiwara, A Fushimi, N Yamashita, A Bhattacharya, H Rajabi, ... Oncogene, 1-11, 2021 | 47 | 2021 |
| The calcium channel proteins ORAI3 and STIM1 mediate TGF-β induced Snai1 expression A Bhattacharya, J Kumar, K Hermanson, Y Sun, H Qureshi, D Perley, ... Oncotarget 9 (50), 29468, 2018 | 32 | 2018 |
| MUC1-C dictates JUN and BAF-mediated chromatin remodeling at enhancer signatures in cancer stem cells A Bhattacharya, A Fushimi, N Yamashita, M Hagiwara, Y Morimoto, ... Molecular Cancer Research 20 (4), 556-567, 2022 | 22 | 2022 |
| Role of flavonoids as epigenetic modulators in cancer prevention and therapy N Fatima, SSR Baqri, A Bhattacharya, NKK Koney, K Husain, A Abbas, ... Frontiers in Genetics 12, 758733, 2021 | 21 | 2021 |
| MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer M Hagiwara, A Fushimi, A Bhattacharya, N Yamashita, Y Morimoto, M Oya, ... Oncoimmunology 11 (1), 2029298, 2022 | 20 | 2022 |
| MUC1-C dictates PBRM1-mediated chronic induction of interferon signaling, DNA damage resistance, and immunosuppression in triple-negative breast cancer N Yamashita, Y Morimoto, A Fushimi, R Ahmad, A Bhattacharya, ... Molecular Cancer Research 21 (3), 274-289, 2023 | 17 | 2023 |
| Targeting MUC1-C suppresses chronic activation of cytosolic nucleotide receptors and STING in triple-negative breast cancer N Yamashita, A Fushimi, Y Morimoto, A Bhattacharya, M Hagiwara, ... Cancers 14 (11), 2580, 2022 | 17 | 2022 |
| MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas Z Luan, Y Morimoto, A Fushimi, N Yamashita, W Suo, A Bhattacharya, ... Carcinogenesis 43 (1), 67-76, 2022 | 12 | 2022 |
| MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells Y Morimoto, N Yamashita, T Daimon, H Hirose, S Yamano, N Haratake, ... Journal for Immunotherapy of Cancer 11 (2), 2023 | 11 | 2023 |
| Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment Y Morimoto, A Fushimi, N Yamashita, M Hagiwara, A Bhattacharya, ... Oncogene 41 (27), 3511-3523, 2022 | 10 | 2022 |
| Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non–neuroendocrine Small Cell Lung Cancer A Fushimi, Y Morimoto, S Ishikawa, N Yamashita, A Bhattacharya, ... Molecular Cancer Research 20 (9), 1379-1390, 2022 | 9 | 2022 |
| MUC1-C is necessary for SHP2 activation and BRAF inhibitor resistance in BRAF (V600E) mutant colorectal cancer Y Morimoto, N Yamashita, H Hirose, A Fushimi, N Haratake, T Daimon, ... Cancer letters 559, 216116, 2023 | 7 | 2023 |
| MUC1-C is a common driver of Acquired Osimertinib Resistance in NSCLC N Haratake, H Ozawa, Y Morimoto, N Yamashita, T Daimon, ... Journal of Thoracic Oncology 19 (3), 434-450, 2024 | 5 | 2024 |
| RBMS1 methylation and mRNA expression are differentially regulated in placenta tissue from obese women (P11-131-19) T Alvine, A Dhasarathy, A Bundy, A Bhattacharya, D Darland, J Hur, ... Current Developments in Nutrition 3, nzz048. P11-131-19, 2019 | 4 | 2019 |
| MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progression A Bhattacharya, A Fushimi, K Wang, N Yamashita, Y Morimoto, ... Communications Biology 6 (1), 1030, 2023 | 3 | 2023 |
| ATAC-seq optimization for Cancer Epigenetics research M Cooper, A Ray, A Bhattacharya, A Dhasarathy, M Takaku JoVE (Journal of Visualized Experiments), e64242, 2022 | 3 | 2022 |
| The role of CCCTC binding factor (CTCF) in epithelial to mesenchymal transition (EMT) A Bhattacharya, J Hur, A Dhasarathy The FASEB Journal 31, 593.8-593.8, 2017 | 2 | 2017 |
| XIST and MUC1-C form an auto-regulatory pathway in driving cancer progression K Wang, A Bhattacharya, N Haratake, T Daimon, A Nakashoji, H Ozawa, ... Cell Death & Disease 15 (5), 330, 2024 | 1 | 2024 |
Atsushi FushimiDepartment of Surgery, The Jikei University在 jikei.ac.jp 的电子邮件经过验证
